CS207346B2 - Chemical indication papers - Google Patents
Chemical indication papers Download PDFInfo
- Publication number
- CS207346B2 CS207346B2 CS757593A CS759375A CS207346B2 CS 207346 B2 CS207346 B2 CS 207346B2 CS 757593 A CS757593 A CS 757593A CS 759375 A CS759375 A CS 759375A CS 207346 B2 CS207346 B2 CS 207346B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- iodine
- indicator
- test
- concentration
- chemical indicator
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims description 25
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims abstract description 29
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229940116269 uric acid Drugs 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 25
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 39
- 239000011630 iodine Substances 0.000 claims description 39
- 229910052740 iodine Inorganic materials 0.000 claims description 39
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical group [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 18
- 229920002472 Starch Polymers 0.000 claims description 11
- 229940032147 starch Drugs 0.000 claims description 11
- 239000008107 starch Substances 0.000 claims description 11
- 235000019698 starch Nutrition 0.000 claims description 11
- GUBGYTABKSRVRQ-ASMJPISFSA-N alpha-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 claims description 7
- VFMMPHCGEFXGIP-UHFFFAOYSA-N 7,8-Benzoflavone Chemical compound O1C2=C3C=CC=CC3=CC=C2C(=O)C=C1C1=CC=CC=C1 VFMMPHCGEFXGIP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003365 glass fiber Substances 0.000 claims description 6
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 6
- 239000004800 polyvinyl chloride Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 4
- 229920000856 Amylose Polymers 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920002527 Glycogen Polymers 0.000 claims description 3
- 239000000020 Nitrocellulose Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 229940096919 glycogen Drugs 0.000 claims description 3
- 150000002496 iodine Chemical class 0.000 claims description 3
- 229920001220 nitrocellulos Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 229940080313 sodium starch Drugs 0.000 claims description 3
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 60
- 239000000463 material Substances 0.000 abstract description 18
- 238000000034 method Methods 0.000 abstract description 9
- 230000008021 deposition Effects 0.000 abstract description 2
- 239000002245 particle Substances 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 238000002845 discoloration Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 201000005569 Gout Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- -1 triiodide ions Chemical class 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000011152 fibreglass Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920002160 Celluloid Polymers 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 238000008114 Uric Acid Assay Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000051 modifying effect Effects 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 150000002843 nonmetals Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- VILMUCRZVVVJCA-UHFFFAOYSA-M sodium glycolate Chemical compound [Na+].OCC([O-])=O VILMUCRZVVVJCA-UHFFFAOYSA-M 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- CMPGARWFYBADJI-UHFFFAOYSA-L tungstic acid Chemical compound O[W](O)(=O)=O CMPGARWFYBADJI-UHFFFAOYSA-L 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229920011532 unplasticized polyvinyl chloride Polymers 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
- G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
- Y10T436/148888—Uric acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Examining Or Testing Airtightness (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4871574 | 1974-11-11 | ||
GB48714/74A GB1527225A (en) | 1974-11-11 | 1974-11-11 | Testing device |
Publications (1)
Publication Number | Publication Date |
---|---|
CS207346B2 true CS207346B2 (en) | 1981-07-31 |
Family
ID=26266320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS757593A CS207346B2 (en) | 1974-11-11 | 1975-11-11 | Chemical indication papers |
Country Status (24)
Country | Link |
---|---|
US (1) | US4234313A (en, 2012) |
JP (1) | JPS5171185A (en, 2012) |
AT (1) | AT347600B (en, 2012) |
AU (1) | AU510140B2 (en, 2012) |
BR (1) | BR7507419A (en, 2012) |
CA (1) | CA1086196A (en, 2012) |
CH (1) | CH618016A5 (en, 2012) |
CS (1) | CS207346B2 (en, 2012) |
DE (1) | DE2550634A1 (en, 2012) |
DK (1) | DK506775A (en, 2012) |
ES (1) | ES442507A1 (en, 2012) |
FI (1) | FI753157A7 (en, 2012) |
FR (1) | FR2290663A1 (en, 2012) |
GR (1) | GR57850B (en, 2012) |
HU (1) | HU176045B (en, 2012) |
IE (1) | IE42062B1 (en, 2012) |
IL (1) | IL48458A (en, 2012) |
IN (1) | IN144448B (en, 2012) |
IT (1) | IT1052184B (en, 2012) |
NL (1) | NL7513185A (en, 2012) |
NO (1) | NO753773L (en, 2012) |
PH (1) | PH14494A (en, 2012) |
SE (1) | SE7512632L (en, 2012) |
YU (1) | YU284975A (en, 2012) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51151190A (en) * | 1975-06-19 | 1976-12-25 | Sugiyama Sangyo Kagaku Kenkyusho | Testing paper for measurement of oil and fat peroxide value |
NO770196L (no) * | 1976-01-22 | 1977-07-25 | Wellcome Found | Kjemiske pr¦vesystemer. |
DE2744046A1 (de) * | 1977-09-30 | 1979-04-12 | Boehringer Mannheim Gmbh | Schnelldiagnosticum zur bestimmung von harnsaeure in koerperfluessigkeiten |
US4387164A (en) * | 1980-11-05 | 1983-06-07 | Fmc Corporation | Method and apparatus for chemical analysis using reactive reagents dispersed in soluble film |
CA1226792A (en) * | 1983-05-12 | 1987-09-15 | Steven C. Charlton | Ion test means having a hydrophilic carrier matrix |
CA1222438A (en) * | 1983-05-12 | 1987-06-02 | Steven C. Charlton | Unified test means for ion determination |
US4523852A (en) * | 1983-06-09 | 1985-06-18 | Miles Laboratories, Inc. | Color comparison reference standard and method for using same |
CA1253057A (en) * | 1984-02-24 | 1989-04-25 | Mary L. Gantzer | Ion test means having a porous carrier matrix |
US4855228A (en) * | 1987-09-11 | 1989-08-08 | Miles Inc. | Multiple oxidative indicator system for visual determination of hydrogen peroxide |
US5071772A (en) * | 1988-02-08 | 1991-12-10 | Raffaele Beli | Device for carrying out extemporaneous quantitative diagnostic tests on whole blood |
CA1322324C (en) * | 1988-02-10 | 1993-09-21 | Joel M. Blatt | Self-indicating and improved resolution analyses employing stoichiometric chemical subtraction |
US5268054A (en) * | 1990-01-31 | 1993-12-07 | Bakhos Youssef G | Mounted micro-samples of powdered solids and method of preparing the same |
GB9308411D0 (en) * | 1993-04-23 | 1993-06-09 | Celsis Ltd | Detection of biological material |
US5603897A (en) * | 1994-06-30 | 1997-02-18 | Bausch & Lomb Incorporated | Method for indicating neutralization of contact lens disinfecting solutions |
US6512857B1 (en) * | 1997-05-09 | 2003-01-28 | Sarnoff Corporation | Method and apparatus for performing geo-spatial registration |
US6699720B1 (en) * | 2000-05-26 | 2004-03-02 | Development Center For Biotechnology | Interference-eliminating membranes, test strips, kits and methods for use in uric acid assay |
EP1837787A1 (en) * | 2006-03-24 | 2007-09-26 | GlucoTel Scientific Inc. | Telemedical method and device for the calibration of measured values |
US10082495B2 (en) | 2016-03-18 | 2018-09-25 | Vision Diagnostics, Inc. | Methods for the detection of oxidative adulterants in urine sample |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB564750A (en) | 1943-03-04 | 1944-10-11 | Horace Ingleson | Means for determining the salinity of salt solutions |
NL289920A (en, 2012) * | 1951-01-28 | |||
US2785057A (en) * | 1953-12-08 | 1957-03-12 | Union Central Life Insurance C | Device for testing liquids |
NL198803B (en, 2012) | 1955-07-07 | 1960-05-16 | ||
US3485587A (en) * | 1956-02-29 | 1969-12-23 | Miles Lab | Protein indicator |
US2986453A (en) * | 1957-11-13 | 1961-05-30 | Miles Lab | Diagnostic compositions |
US2996436A (en) * | 1958-06-02 | 1961-08-15 | Sigma Chem Co | Process for the colorimetric determination of lactic dehydrogenase |
US3139328A (en) * | 1960-07-21 | 1964-06-30 | Sun Oil Co | Indicator paper |
US3258312A (en) | 1960-11-17 | 1966-06-28 | Minnesota Mining & Mfg | Ethylene oxide monitoring method and sheet material, and packages bearing same |
NL134608C (en, 2012) | 1963-06-17 | |||
NL129843C (en, 2012) * | 1965-05-20 | |||
US3552928A (en) * | 1967-07-19 | 1971-01-05 | Miles Lab | Whole blood separation means and test system using same |
US3536448A (en) * | 1967-07-28 | 1970-10-27 | Miles Lab | Uric acid detection |
US3511608A (en) * | 1967-12-14 | 1970-05-12 | Harold P Anderson | Multiple layer paper test strip |
US3607093A (en) * | 1968-02-15 | 1971-09-21 | Schering Corp | Devices for testing biological liquids |
GB1205908A (en) | 1968-05-13 | 1970-09-23 | Sylvania Electric Prod | Photoflash lamp |
US3528777A (en) * | 1968-09-27 | 1970-09-15 | Hycel Inc | Process and compositions for determination of uric acid in blood serum |
US3814668A (en) | 1969-10-15 | 1974-06-04 | Miles Lab | Method and device for the semi-quantitative determination of glucose in aqueous fluids |
US3649198A (en) * | 1970-05-19 | 1972-03-14 | Pfizer & Co C | Diagnostic method for the determination of uric acid in blood |
GB1290426A (en, 2012) | 1970-09-28 | 1972-09-27 | ||
GB1282089A (en) * | 1970-10-28 | 1972-07-19 | Miles Lab | Composition for the detection of uric acid |
DE2130559C3 (de) | 1971-06-19 | 1973-11-22 | Boehringer Mannheim Gmbh, 6800 Mannheim | Diagnostisches Mittel zum Nach weis von Urobihnogen |
US3798004A (en) * | 1972-04-18 | 1974-03-19 | Ames Yissum Ltd | Test device |
DE2319831A1 (de) | 1972-04-25 | 1973-12-13 | Ciba Geigy Ag | Indikatorpapier |
US3822115A (en) * | 1972-08-30 | 1974-07-02 | Medico Electronic Inc | Method and reagent for uric acid determination |
US3846247A (en) * | 1972-09-27 | 1974-11-05 | Warner Lambert Co | Moisture barrier |
US4141688A (en) * | 1977-08-11 | 1979-02-27 | Miles Laboratories, Inc. | Composition, device and method for determining reducing agents |
-
1975
- 1975-11-07 AT AT848475A patent/AT347600B/de not_active IP Right Cessation
- 1975-11-10 CA CA239,607A patent/CA1086196A/en not_active Expired
- 1975-11-10 FR FR7534270A patent/FR2290663A1/fr active Granted
- 1975-11-11 YU YU02849/75A patent/YU284975A/xx unknown
- 1975-11-11 NL NL7513185A patent/NL7513185A/xx not_active Application Discontinuation
- 1975-11-11 CS CS757593A patent/CS207346B2/cs unknown
- 1975-11-11 SE SE7512632A patent/SE7512632L/ unknown
- 1975-11-11 ES ES442507A patent/ES442507A1/es not_active Expired
- 1975-11-11 NO NO753773A patent/NO753773L/no unknown
- 1975-11-11 AU AU86498/75A patent/AU510140B2/en not_active Expired
- 1975-11-11 IT IT52168/75A patent/IT1052184B/it active
- 1975-11-11 GR GR49345A patent/GR57850B/el unknown
- 1975-11-11 JP JP50135579A patent/JPS5171185A/ja active Pending
- 1975-11-11 PH PH17760A patent/PH14494A/en unknown
- 1975-11-11 DE DE19752550634 patent/DE2550634A1/de not_active Withdrawn
- 1975-11-11 IE IE2456/75A patent/IE42062B1/en unknown
- 1975-11-11 FI FI753157A patent/FI753157A7/fi not_active Application Discontinuation
- 1975-11-11 IL IL48458A patent/IL48458A/xx unknown
- 1975-11-11 HU HU75WE529A patent/HU176045B/hu unknown
- 1975-11-11 DK DK506775A patent/DK506775A/da unknown
- 1975-11-11 CH CH1457875A patent/CH618016A5/de not_active IP Right Cessation
- 1975-11-11 BR BR7507419*A patent/BR7507419A/pt unknown
-
1976
- 1976-05-07 IN IN797/CAL/76A patent/IN144448B/en unknown
-
1978
- 1978-06-05 US US05/912,349 patent/US4234313A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2290663A1 (fr) | 1976-06-04 |
AU8649875A (en) | 1977-05-19 |
DE2550634A1 (de) | 1976-05-13 |
JPS5171185A (en, 2012) | 1976-06-19 |
IE42062B1 (en) | 1980-05-21 |
IT1052184B (it) | 1981-06-20 |
GR57850B (en) | 1977-07-04 |
SE7512632L (sv) | 1976-05-12 |
US4234313A (en) | 1980-11-18 |
NO753773L (en, 2012) | 1976-05-12 |
IL48458A0 (en) | 1976-01-30 |
IL48458A (en) | 1979-03-12 |
YU284975A (en) | 1982-06-30 |
HU176045B (en) | 1980-11-28 |
BR7507419A (pt) | 1976-08-03 |
CH618016A5 (en, 2012) | 1980-06-30 |
AU510140B2 (en) | 1980-06-12 |
ES442507A1 (es) | 1977-08-16 |
IN144448B (en, 2012) | 1978-05-06 |
FI753157A7 (en, 2012) | 1976-05-12 |
AT347600B (de) | 1979-01-10 |
CA1086196A (en) | 1980-09-23 |
DK506775A (da) | 1976-05-12 |
ATA848475A (de) | 1978-05-15 |
NL7513185A (nl) | 1976-05-13 |
IE42062L (en) | 1976-05-11 |
PH14494A (en) | 1981-08-14 |
FR2290663B1 (en, 2012) | 1981-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS207346B2 (en) | Chemical indication papers | |
CA2210770C (en) | Diagnostic test carrier with multi-layer test field and method in which it is used to determine and analyte | |
US5128171A (en) | Method of making a test strip having a dialyzed polymer layer | |
US4952515A (en) | Method of detection using a test strip having a non particulate dialyzed polymer layer | |
US4814142A (en) | Test strip having a non-particulate dialyzed polymer layer | |
US3298789A (en) | Test article for the detection of glucose | |
US5300439A (en) | Method, device, and composition for the assay of ions | |
CA2210652C (en) | Volume-independent diagnostic test carrier and methods in which it is used to determine an analyte | |
EP0020788B1 (en) | Test piece for measuring glucose | |
CA1054035A (en) | Biological fluid tests strip | |
US4994238A (en) | Constant volume chemical analysis test device | |
US4057394A (en) | Test device and method for determining blood hemoglobin | |
US3733179A (en) | Method and apparatus for the quantitative determination of blood chemicals in blood derivatives | |
US3485587A (en) | Protein indicator | |
CA1341135C (en) | Process and reagent for the determination of the ionic strength or of the specific weight of aqueous liquids | |
US4273868A (en) | Color stable glucose test | |
US5055407A (en) | Composition and method of assaying aqueous liquids for specific gravity | |
PL106419B1 (pl) | Srodek do oznaczania kwasu moczowego | |
US3447904A (en) | Test indicator for the detection of chlorides | |
US5755231A (en) | Test strip including integral specimen flow retarding structure | |
JPS585673B2 (ja) | 過酸化活性物質検出用試験組成物 | |
EP0036563B1 (en) | Bilirubin-resistant composition for the determination of cholesterol, test device containing the composition and method of making the test device | |
US4132527A (en) | Diagnostic compositions, diagnosing instruments, and methods of manufacturing same | |
EP0041175B1 (en) | Ion specific analytical element | |
Levinson | Kinetic centrifugal analyzer and manual determination of serum urea nitrogen, with use of o-phthaldialdehyde reagent. |